cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Chinook Therapeutics Inc
2 own
3 watching
Current Price
$0
$0.25
(1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,600.39M
52-Week High
52-Week High
27.44
52-Week Low
52-Week Low
15.08
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,600.39M
icon52-Week High27.44
icon52-Week Low15.08
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio--
What does the Chinook Therapeutics Inc do?
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company s lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.
Read More
How much money does Chinook Therapeutics Inc make?
News & Events about Chinook Therapeutics Inc.
Globe Newswire
17hours ago
NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against JinkoSolar Holding Co., Ltd. (NYSE: JKS), Integra LifeSciences Holdings Corp. (NASDAQ: IART), and Chinook Therapeutics, Inc. (NASDAQ...
PR Newswire
6hours ago
CHINOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Chinook To Contact Him Directly To Discuss Their Options CHINOOK SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson...
Globe Newswire
2 months ago
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced presentations at the ISN World Congress of Nephrology 2023 from ...
Globe Newswire
3 months ago
SEATTLE, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the appointment of Andrew Oxtoby as chief commercial officer. We ...
Globe Newswire
7 months ago
BION-1301 Treatment Results in Rapid and Durable Reductions in IgA and Gd-IgA1 in Patients with IgA Nephropathy Following both IV and SC dosing, BION-1301 produced rapid and sustained reductions in IgA and Gd-IgA1, the pathogenic variant of IgA nephropathy BION-1301 Treatment Results in ...
Frequently Asked Questions
Frequently Asked Questions
What is Chinook Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Chinook Therapeutics Inc shares?
plus_minus_icon
How can I buy Chinook Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Chinook Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Chinook Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Chinook Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Chinook Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Chinook Therapeutics Inc?
plus_minus_icon
What percentage is Chinook Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Chinook Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.25
(1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00